Opus Genetics Inc Revenue per Employee (IRD), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Opus Genetics Inc   (NASDAQ: IRD)
 

Opus Genetics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Opus Genetics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 352,000, below the company average number of $627,470.
Within the Healthcare sector Employees of 217 other companies have achieved higher revenue per employee. While Opus Genetics Inc 's total ranking has deteriorated compared to the previous quarter from 1500 to 1863. Opus Genetics Inc has 28 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IRD Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change -73.8 % -50.64 % -10.16 % -20.38 % 159.17 %
Sales per Employee (TTM) $ 352,000 427,964 507,000 522,607 550,750
IRD's Total Ranking # 1863 # 1500 # 889 # 0 # 0
Seq. Revenue Change -65 % -44.19 % 25.53 % 6.84 % -34.05 %

IRD Company Profile >> Back to IRD Efficiency Comparisons >> Compare IRD Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 120
Healthcare Sector # 218
Overall Market # 1863

Revenue per Employee Statistics
High Average Low
$ 2,043,143 $ 627,470 $ 299,321
(Sep 30 2023)   (Sep 30 2024)



Financial Statements
Opus Genetics Inc 's Revenue MRQ $ 1 Millions Visit IRD's Income Statement
Opus Genetics Inc 's Revenues TTM $ 10 Millions Visit IRD's aggregate revenue growth
What are IRD's Sales? Visit IRD's Sales by Segment




Other Ratios
Opus Genetics Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
IRD's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for IRD's Competitors
Revenue per Employee for IRD's Suppliers
Revenue per Employee for IRD's Customers

You may also want to know
IRD's Sales Growth Rates IRD's Pe Price to earnings ratio IRD's Receivables Turnover Ratio IRD's Stock Quote
IRD's Net Income Growth Rates IRD's Ps Price to Sales ratio IRD's Sales per Employee IRD's Asset Turnover Ratio
IRD's Net Margin IRD's Pb Price to Book ratio IRD's Financial Strength Ratios IRD's Dividend Payout Ratio
Date modified: 2026-09-05T15:15:09+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Organon and Co   613,900.00 $ 6,139.000  Million 10,000 
Nature s Sunshine Products inc   610,161.29 $ 491.790  Million 806 
Delcath Systems Inc   602,935.90 $ 94.058  Million 156 
Nephros Inc   602,388.89 $ 21.686  Million 36 
Caredx Inc   598,809.15 $ 458.089  Million 765 
Jaguar Health Inc   591,808.51 $ 27.815  Million 47 
Milestone Scientific Inc   590,317.47 $ 8.855  Million 15 
Waters Corporation  587,879.62 $ 4,644.249  Million 7,900 
Phibro Animal Health Corporation  582,288.29 $ 1,516.861  Million 2,605 
Rhythm Pharmaceuticals Inc   579,512.08 $ 239.918  Million 414 
Macrogenics Inc   572,266.21 $ 167.674  Million 293 
Si bone inc   570,029.26 $ 214.331  Million 376 
Cardiff Lexington Corporation  567,380.00 $ 10.213  Million 18 
Insulet Corporation  565,444.44 $ 3,053.400  Million 5,400 
Novavax inc   552,464.62 $ 413.796  Million 749 
Embecta Corp   551,189.19 $ 1,019.700  Million 1,850 
Iridex Corp  548,860.22 $ 51.044  Million 93 
Henry Schein Inc   544,080.00 $ 13,602.000  Million 25,000 
Enanta Pharmaceuticals Inc  543,816.67 $ 65.258  Million 120 
Editas Medicine Inc   540,287.36 $ 47.005  Million 87 
Organogenesis Holdings Inc   535,660.42 $ 457.454  Million 854 
Bausch Health Companies Inc   534,630.54 $ 10,853.000  Million 20,300 
Instil Bio Inc   527,529.41 $ 8.968  Million 17 
Globus Medical Inc   524,155.67 $ 3,144.934  Million 6,000 
10x Genomics Inc   523,400.68 $ 616.566  Million 1,178 
Ultragenyx Pharmaceutical Inc   523,130.56 $ 717.212  Million 1,371 
Iradimed Corporation  520,114.23 $ 86.339  Million 166 
Orthofix Medical Inc   519,217.45 $ 833.344  Million 1,605 
Lexicon Pharmaceuticals Inc   511,962.96 $ 41.469  Million 81 
Perrigo Company Plc  511,604.94 $ 4,144.000  Million 8,100 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.